Pain

Large study comparing spinal cord stimulators to conventional medical management found a lack of clinical benefit for most patients and possible harm to some.

Your daily dose of clinical news you may have missed.

Your daily dose of clinical news you may have missed.

A preliminary assessment from the FDA suggests certain naloxone products may be safely used without a prescription to prevent opioid overdose deaths.

A guideline topline of the CDC's 2022 clinical guidance for prescribing opioids for pain in adults.

The 2022 guidance covers acute, subacute, and chronic pain and replaces the 2016 guidelines.

Gabapentin-involved overdose deaths doubled in Q2 2020 compared to Q1 2019, the CDC reports. What do you know, and maybe not know, about the troubling trend?

A discussion with Lynn Webster, MD, about the importance and future of mobile health technology for chronic pain management.

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Lynn Webster, MD, past president of the American Academy of Pain Medicine.

Benjamin W. Friedman, MD, MS; Francesca Beaudoin, MD, MS, PhD; Paul Arnstein, RN, PhD, FAAN; and Jeff Gudin, MD, provide take-home messages to providers treating patients with acute pain.